14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $64.82 $75.66 Wednesday, 24th Apr 2024 CYTK stock ended at $66.82. This is 1.91% more than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 2.69% from a day low at $65.68 to a day high of $67.45.
90 days $61.33 $84.05
52 weeks $25.98 $110.00

Historical Cytokinetics prices

Date Open High Low Close Volume
Jul 13, 2021 $19.14 $19.45 $18.66 $18.79 1 019 086
Jul 12, 2021 $19.66 $20.00 $19.14 $19.25 702 958
Jul 09, 2021 $19.80 $19.93 $19.30 $19.59 295 997
Jul 08, 2021 $19.39 $20.00 $19.31 $19.73 663 439
Jul 07, 2021 $19.51 $20.22 $19.42 $19.77 654 698
Jul 06, 2021 $20.14 $20.49 $19.33 $19.53 528 220
Jul 02, 2021 $20.92 $21.19 $20.44 $20.61 465 976
Jul 01, 2021 $19.86 $21.15 $19.53 $20.98 1 055 376
Jun 30, 2021 $20.91 $21.07 $19.52 $19.79 1 570 771
Jun 29, 2021 $22.43 $22.80 $21.09 $21.12 935 394
Jun 28, 2021 $22.75 $23.28 $22.50 $22.50 506 537
Jun 25, 2021 $22.60 $22.92 $22.21 $22.50 1 032 757
Jun 24, 2021 $22.50 $23.00 $22.25 $22.55 371 842
Jun 23, 2021 $22.15 $22.42 $21.93 $22.31 449 240
Jun 22, 2021 $21.70 $22.17 $21.28 $22.15 653 615
Jun 21, 2021 $21.55 $22.01 $21.31 $21.77 465 443
Jun 18, 2021 $21.58 $21.76 $20.87 $21.31 686 351
Jun 17, 2021 $21.68 $21.97 $21.19 $21.94 266 067
Jun 16, 2021 $22.19 $22.31 $21.19 $21.79 561 148
Jun 15, 2021 $21.80 $22.82 $21.75 $22.28 1 478 440
Jun 14, 2021 $21.04 $22.00 $21.04 $21.85 1 271 966
Jun 11, 2021 $21.51 $21.81 $20.92 $21.04 445 622
Jun 10, 2021 $21.51 $22.07 $21.25 $21.52 579 658
Jun 09, 2021 $21.84 $22.50 $21.33 $21.53 437 627
Jun 08, 2021 $22.29 $22.56 $21.29 $21.72 332 585
Click to get the best stock tips daily for free!

About Cytokinetics

Cytokinetics Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator that is in Phase III clinical trial in pati... CYTK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT